Leukemia Home > Campath for MS

The primary use for Campath® (alemtuzumab) is to treat leukemia, a type of cancer that affects the blood and bone marrow. At times, a drug may be given to treat a condition it is not approved to treat. This is called an off-label use. Currently accepted off-label uses for Campath include treating multiple sclerosis (MS) and rheumatoid arthritis, and preventing organ transplant rejection.
(Click Campath Uses for more information on this topic, including how this medicine works and whether children and older adults can use it.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.